 | • レポートコード：QFJ1-4742 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、前がん病変分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・前がん病変分子診断の市場動向 ・企業の競争状況、市場シェア ・前がん病変分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・前がん病変分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・前がん病変分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・前がん病変分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・前がん病変分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・前がん病変分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・前がん病変分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genetronhealth、Sanvalley、Premed、Gene+、Annoroad、Topgen、Anpac、Kingmed、Unitedgene、Roche、Foundationmedicine） ・結論 |
A molecular approach for diagnosing precancer
Market Analysis and Insights: Global Precancer Molecular Diagnostics Market
The global Precancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Precancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Precancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Precancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Precancer Molecular Diagnostics market.
Global Precancer Molecular Diagnostics Scope and Market Size
Precancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Precancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Genetronhealth
Sanvalley
Premed
Gene+
Annoroad
Topgen
Anpac
Kingmed
Unitedgene
Roche
Foundationmedicine
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Precancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Precancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Precancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Precancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Precancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Precancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Precancer Molecular Diagnostics Industry Dynamic
2.3.1 Precancer Molecular Diagnostics Market Trends
2.3.2 Precancer Molecular Diagnostics Market Drivers
2.3.3 Precancer Molecular Diagnostics Market Challenges
2.3.4 Precancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Precancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Precancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Precancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Precancer Molecular Diagnostics Revenue
3.4 Global Precancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Precancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precancer Molecular Diagnostics Revenue in 2020
3.5 Precancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Precancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Precancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Precancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Precancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)
5 Precancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Precancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Precancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Precancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Precancer Molecular Diagnostics Market Size by Type
6.2.1 North America Precancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Precancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Precancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Precancer Molecular Diagnostics Market Size by Application
6.3.1 North America Precancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Precancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Precancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Precancer Molecular Diagnostics Market Size by Country
6.4.1 North America Precancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Precancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Precancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Precancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Precancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Precancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Precancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Precancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Precancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Precancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Precancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Precancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Precancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Precancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Precancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Precancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Precancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Precancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Precancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Precancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Precancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Precancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Precancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Precancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Precancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Precancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Precancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Precancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Precancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Precancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Precancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Precancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Precancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Precancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Precancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Precancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Precancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Precancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Precancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Precancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Precancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Precancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Precancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Precancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Precancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Precancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Precancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Precancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Precancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Genetronhealth
11.1.1 Genetronhealth Company Details
11.1.2 Genetronhealth Business Overview
11.1.3 Genetronhealth Precancer Molecular Diagnostics Introduction
11.1.4 Genetronhealth Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.1.5 Genetronhealth Recent Development
11.2 Sanvalley
11.2.1 Sanvalley Company Details
11.2.2 Sanvalley Business Overview
11.2.3 Sanvalley Precancer Molecular Diagnostics Introduction
11.2.4 Sanvalley Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.2.5 Sanvalley Recent Development
11.3 Premed
11.3.1 Premed Company Details
11.3.2 Premed Business Overview
11.3.3 Premed Precancer Molecular Diagnostics Introduction
11.3.4 Premed Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.3.5 Premed Recent Development
11.4 Gene+
11.4.1 Gene+ Company Details
11.4.2 Gene+ Business Overview
11.4.3 Gene+ Precancer Molecular Diagnostics Introduction
11.4.4 Gene+ Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.4.5 Gene+ Recent Development
11.5 Annoroad
11.5.1 Annoroad Company Details
11.5.2 Annoroad Business Overview
11.5.3 Annoroad Precancer Molecular Diagnostics Introduction
11.5.4 Annoroad Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.5.5 Annoroad Recent Development
11.6 Topgen
11.6.1 Topgen Company Details
11.6.2 Topgen Business Overview
11.6.3 Topgen Precancer Molecular Diagnostics Introduction
11.6.4 Topgen Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.6.5 Topgen Recent Development
11.7 Anpac
11.7.1 Anpac Company Details
11.7.2 Anpac Business Overview
11.7.3 Anpac Precancer Molecular Diagnostics Introduction
11.7.4 Anpac Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.7.5 Anpac Recent Development
11.8 Kingmed
11.8.1 Kingmed Company Details
11.8.2 Kingmed Business Overview
11.8.3 Kingmed Precancer Molecular Diagnostics Introduction
11.8.4 Kingmed Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.8.5 Kingmed Recent Development
11.9 Unitedgene
11.9.1 Unitedgene Company Details
11.9.2 Unitedgene Business Overview
11.9.3 Unitedgene Precancer Molecular Diagnostics Introduction
11.9.4 Unitedgene Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.9.5 Unitedgene Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Precancer Molecular Diagnostics Introduction
11.10.4 Roche Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Foundationmedicine
11.11.1 Foundationmedicine Company Details
11.11.2 Foundationmedicine Business Overview
11.11.3 Foundationmedicine Precancer Molecular Diagnostics Introduction
11.11.4 Foundationmedicine Revenue in Precancer Molecular Diagnostics Business (2016-2021)
11.11.5 Foundationmedicine Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Precancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Precancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Precancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Precancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Precancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Precancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Precancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Precancer Molecular Diagnostics Market Trends
Table 13. Precancer Molecular Diagnostics Market Drivers
Table 14. Precancer Molecular Diagnostics Market Challenges
Table 15. Precancer Molecular Diagnostics Market Restraints
Table 16. Global Precancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Precancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Precancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Precancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Precancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Precancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Precancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Precancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Precancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Precancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Precancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Precancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Precancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Precancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Precancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Precancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Precancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Precancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Precancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Precancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Precancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Precancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Precancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Precancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Precancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Precancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Precancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Precancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Precancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Precancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Precancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Precancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Precancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Precancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Precancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Precancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Precancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Precancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Precancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Precancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Precancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Precancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Precancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Precancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Precancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Genetronhealth Company Details
Table 64. Genetronhealth Business Overview
Table 65. Genetronhealth Precancer Molecular Diagnostics Product
Table 66. Genetronhealth Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Genetronhealth Recent Development
Table 68. Sanvalley Company Details
Table 69. Sanvalley Business Overview
Table 70. Sanvalley Precancer Molecular Diagnostics Product
Table 71. Sanvalley Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Sanvalley Recent Development
Table 73. Premed Company Details
Table 74. Premed Business Overview
Table 75. Premed Precancer Molecular Diagnostics Product
Table 76. Premed Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Premed Recent Development
Table 78. Gene+ Company Details
Table 79. Gene+ Business Overview
Table 80. Gene+ Precancer Molecular Diagnostics Product
Table 81. Gene+ Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Gene+ Recent Development
Table 83. Annoroad Company Details
Table 84. Annoroad Business Overview
Table 85. Annoroad Precancer Molecular Diagnostics Product
Table 86. Annoroad Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Annoroad Recent Development
Table 88. Topgen Company Details
Table 89. Topgen Business Overview
Table 90. Topgen Precancer Molecular Diagnostics Product
Table 91. Topgen Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Topgen Recent Development
Table 93. Anpac Company Details
Table 94. Anpac Business Overview
Table 95. Anpac Precancer Molecular Diagnostics Product
Table 96. Anpac Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Anpac Recent Development
Table 98. Kingmed Company Details
Table 99. Kingmed Business Overview
Table 100. Kingmed Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Kingmed Recent Development
Table 102. Unitedgene Company Details
Table 103. Unitedgene Business Overview
Table 104. Unitedgene Precancer Molecular Diagnostics Product
Table 105. Unitedgene Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Unitedgene Recent Development
Table 107. Roche Company Details
Table 108. Roche Business Overview
Table 109. Roche Precancer Molecular Diagnostics Product
Table 110. Roche Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Roche Recent Development
Table 112. Foundationmedicine Company Details
Table 113. Foundationmedicine Business Overview
Table 114. Foundationmedicine Precancer Molecular Diagnostics Product
Table 115. Foundationmedicine Revenue in Precancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Foundationmedicine Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Precancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Precancer Molecular Diagnostics Report Years Considered
Figure 11. Global Precancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Precancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Precancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Precancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Precancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Precancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Precancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Precancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Precancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Precancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Precancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Precancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Precancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Precancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Precancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Precancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Precancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Precancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Precancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Precancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Precancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Precancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Precancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Precancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Precancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genetronhealth Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 60. Sanvalley Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 61. Premed Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 62. Gene+ Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 63. Annoroad Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 64. Topgen Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 65. Anpac Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 66. Kingmed Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 67. Unitedgene Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 69. Foundationmedicine Revenue Growth Rate in Precancer Molecular Diagnostics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing laryngeal cancer Market Analysis and Insights: Global Laryngeal Cancer Molecular Diagnostics Market The global Laryngeal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…- 世界の黒色腫分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing melanoma Market Analysis and Insights: Global Melanoma Molecular Diagnostics Market The global Melanoma Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-st…
- 世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing bladder cancer Market Analysis and Insights: Global Bladder Cancer Molecular Diagnostics Market The global Bladder Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
- 世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing pancreatic cancer Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
- 世界の消化管間質腫瘍分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing gastrointestinal Stromal Tumor Market Analysis and Insights: Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market The global Gastrointestinal Stromal Tumor Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 202…